NEWS
professionals about diabetes technology."
Michael Goetzl, Managing Director,
Roche Diabetes Care UK & Ireland
added, "We are delighted to support
healthcare professionals in furthering their
understanding of diabetes technology
with this collaboration with GlookoDiasend and DTN. By enhancing skills in
the technology space we are also helping
to reduce barriers to technology access
for people with diabetes, ultimately
improving their care."
About Academy
It is hoped that the Academy platform
will reduce barriers to the commissioning
of innovation and technology in the
future. Several NHS trusts have been
reluctant to offer technology solutions,
not understanding the value they bring
to people living with diabetes. Benefits
of using diabetes technologies such as
CGM sensors and carb-counting apps,
as examples, include improved HbA1c
results which are linked with a reduced
risk of long-term conditions, improved
quality of life and a lessening of the burden
of living with the condition.
DTN will provide guidance on content
and they will ensure that the educational
programme aligns with current and future
NHSE policy/pathways. They will also
ensure that the platform has the
reporting capabilities needed to
demonstrate clinical competencies
that inform commissioning
decisions.
The programme will be
accessible to diabetes specialist
healthcare professionals in the UK
at no cost to the individual or the
NHS, and the platform will remain
agnostic to both diabetes device
manufacturers and products. It
will have the capability to certify
that healthcare professionals have
completed a course, alongside
clinic-level reporting functionality
to clearly demonstrate where
the ABCD training has been
completed in these technologies.
www.roche.co.uk
ACCU-CHEK INSTANT including
a Fastclix lancing device, meter,
mySugr app and test strips.
"By enhancing skills in the technology space
we are also helping to reduce barriers
to technology access for people with
diabetes, ultimately improving their care. -
Michael Goetzl, MD, Roche UK (right).